Cargando…

Towards Next Generation Biomarkers in Natural Killer/T-Cell Lymphoma

Natural killer/T-cell lymphoma (NKTCL) is an Epstein–Barr virus-associated non-Hodgkin lymphoma linked to an aggressive clinical course and poor prognosis. Despite an improvement in survival outcomes with the incorporation of novel agents including immune checkpoint inhibitors in the treatment of NK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Jason Yongsheng, Lim, Jing Quan, Ong, Choon Kiat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398475/ https://www.ncbi.nlm.nih.gov/pubmed/34440582 http://dx.doi.org/10.3390/life11080838

Ejemplares similares

Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma
por: Yap, Daniel Ren Yi, et al.
Publicado: (2023)

Pathogenesis and biomarkers of natural killer T cell lymphoma (NKTL)
por: Somasundaram, Nagavalli, et al.
Publicado: (2019)

Checkpoint immunotherapy for NK/T cell lymphoma—Time for a showdown?
por: Chan, Jason Yongsheng, et al.
Publicado: (2021)

A clinicohaematological prognostic model for nasal-type natural killer/T-cell lymphoma: A multicenter study
por: Tan, Khee Ming, et al.
Publicado: (2019)

Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma
por: Zhou, Jianbiao, et al.
Publicado: (2023)

No association between ECSIT germline mutations and hemophagocytic lymphohistiocytosis in natural killer/T-cell lymphoma
por: Ong, Shin Yeu, et al.
Publicado: (2020)

Next Generation Natural Killer Cells for Cancer Immunotherapy
por: Rossi, Fiorella, et al.
Publicado: (2022)

Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma
por: Peng, Rou-Jun, et al.
Publicado: (2018)

Whole-genome sequencing identifies responders to Pembrolizumab in relapse/refractory natural-killer/T cell lymphoma
por: Lim, Jing Quan, et al.
Publicado: (2020)

Preclinical characterization of WB737, a potent and selective STAT3 inhibitor, in natural killer/T‐cell lymphoma
por: Wang, Yali, et al.
Publicado: (2023)

Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?
por: Ben-Shmuel, Aviad, et al.
Publicado: (2020)

Harnessing natural killer cells to develop next‐generation cellular immunotherapy
por: Liu, Siyao, et al.
Publicado: (2022)

Towards precision oncology in angiosarcomas using next generation “omic” technologies
por: Tan, Grace Fangmin, et al.
Publicado: (2021)

Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations
por: Chan, Jason Yongsheng, et al.
Publicado: (2023)

Delayed Diagnosis of Nasal Natural Killer/T-Cell Lymphoma
por: Villwock, Jennifer A., et al.
Publicado: (2013)

Analytical and clinical validation of an amplicon-based next generation sequencing assay for ultrasensitive detection of circulating tumor DNA
por: Poh, Jonathan, et al.
Publicado: (2022)

Extranodal natural killer/T-cell lymphoma of the tenosynovium of the hand
por: Lim, Yoo Li, et al.
Publicado: (2015)

T-cell dysfunction in natural killer/T-cell lymphoma
por: Feng, Xiaoyan, et al.
Publicado: (2023)

Evaluation of the PIK3 pathway in peripheral T‐cell lymphoma and NK/T‐cell lymphoma
por: Huang, Dachuan, et al.
Publicado: (2020)

Natural killer cells: the next wave in cancer immunotherapy
por: Chen, Xin, et al.
Publicado: (2022)

Treatment outcomes of T and natural‐killer/T‐cell lymphoma with ifosfamide, carboplatin and etoposide chemotherapy
por: Tay, Tricia, et al.
Publicado: (2022)

Primary Natural Killer/T-Cell Lymphoma of the Ribs
por: Kim, Kyoung Min, et al.
Publicado: (2023)

Prognostic biomarkers in patients with localized natural killer/T-cell lymphoma treated with concurrent chemoradiotherapy
por: Yamaguchi, Motoko, et al.
Publicado: (2014)

Gut microbiota as non-invasive diagnostic and prognostic biomarkers for natural killer/T-cell lymphoma
por: Shi, Zhuangzhuang, et al.
Publicado: (2023)

Misaligned sequencing reads from the GNAQ-pseudogene locus may yield GNAQ artefact variants
por: Lim, Jing Quan, et al.
Publicado: (2022)

Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type
por: Gill, Harinder, et al.
Publicado: (2010)

Treatment outcome of nasal natural killer/T-cell lymphoma
por: Lee, Hyun Jin, et al.
Publicado: (2011)

Advances in multiple omics of natural-killer/T cell lymphoma
por: Xiong, Jie, et al.
Publicado: (2018)

Extranodal Natural Killer/T-Cell Lymphoma: An Incidental Finding
por: Althoff, Ashley, et al.
Publicado: (2017)

Non-coding RNAs in Natural Killer/T-Cell Lymphoma
por: Mei, Mei, et al.
Publicado: (2019)

Updating targets for natural killer/T-cell lymphoma immunotherapy
por: Xue, Weili, et al.
Publicado: (2021)

Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma
por: Tian, Xiao-Peng, et al.
Publicado: (2023)

Extranodal nasal-type natural killer/T-cell lymphoma with penile involvement: a case report and review of the literature
por: Wang, Xiaotian, et al.
Publicado: (2017)

Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma
por: Peng, Yin-yin, et al.
Publicado: (2021)

First case of primary intraocular natural killer t-cell lymphoma
por: Maruyama, Kazuichi, et al.
Publicado: (2015)

Extranasal natural killer/T-cell lymphoma initially presenting as myelofibrosis
por: Jang, Woori, et al.
Publicado: (2016)

Extranodal natural killer/T-cell lymphoma presenting as orbital cellulitis
por: Zuhaimy, Hanis, et al.
Publicado: (2017)

Blastic natural killer cell lymphoma/leukaemia in a cat
por: Hirabayashi, Miyuki, et al.
Publicado: (2019)

Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma
por: Cai, Qingqing, et al.
Publicado: (2019)

Calreticulin increases growth and progression of natural killer/T-cell lymphoma
por: Zheng, Yan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2nmt0t6nh81afs62a0jr9dsgst